<DOC>
	<DOC>NCT02719210</DOC>
	<brief_summary>All the children with acute liver failure who are candidates for transplant but have constraints for transplant will be randomized either to receive standard medical therapy or high volume plasma exchange along with standard medical therapy with the aim to assess the effect of high volume plasma exchange on transplant free survival.</brief_summary>
	<brief_title>High Volume Plasma Exchange in Children With Acute Liver Failure</brief_title>
	<detailed_description />
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Liver Failure, Acute</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<criteria>Children ≥ 10kg with ALF with INR ≥ 4 or INR ≥ 3 with Hepatic Encephalopathy. 1. Evidence of active infection (Age specific neutrophilic leucocytosis (ANC) and procalcitonin ≥ 2 and/or focus of active infection 2. Refusal of consent or assent (annexure 3) 3. Liver resections with liver failure 4. Patients with clinical suspicion of irreversible brain injury 5. Patients with acute kidney injury</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>